Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study.
Falasca
L
L
Department of Surgery, University of Rome Tor Vergata, Italy.
Tisone
G
G
Orlando
G
G
Baiocchi
L
L
Vennerecci
G
G
Anselmo
A
A
Torri
E
E
Di Paolo
D
D
Strati
F
F
Casciani
C U
CU
Angelico
M
M
D000241:Adenosine; D000328:Adult; D000493:Allopurinol; D002756:Cholagogues and Choleretics; D005978:Glutathione; D006801:Humans; D007328:Insulin; D008099:Liver / Q000187:drug effects; D016031:Liver Transplantation / Q000473:pathology*; D008875:Middle Aged; D009926:Organ Preservation / Q000379:methods; D019188:Organ Preservation Solutions; D011887:Raffinose; D015427:Reperfusion Injury / Q000517:prevention & control*; D013655:Taurochenodeoxycholic Acid; D014184:Transplantation, Homologous
D002756:Cholagogues and Choleretics; D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D013655:Taurochenodeoxycholic Acid; C031655:ursodoxicoltaurine; D000493:Allopurinol; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose